Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

Medical Sciences division News

COVID-19 Vaccine Study

The Oxford Vaccine Centre, University of Oxford are recruiting now for a new COVID-19 vaccine study.

This study aims to find a safe vaccine that can be used to create immune responses against the virus and thus prevent the disease. We are looking for healthy volunteers aged 18-55 who will be compensated for 4-12 visits over 6-12 months.

For more information, please visit: https://www.covid19vaccinetrial.co.uk/

Read more about the news story here: http://www.ox.ac.uk/news/2020-03-27-oxford-covid-19-vaccine-programme-opens-clinical-trial-recruitment 

Oxford Medical Alumni Network

Sign up for mailings - keep in touch with medicine at Oxford.

Update your detailsMake sure you receive alumni news and event invitations.


What's new

Bacteria perform mass suicide to defend their colony

A new study from researchers at Oxford University’s Departments of Zoology and Biochemistry shows that warring bacteria will engage in suicidal attacks in vast numbers to take down competitors.

Oxford University’s COVID-19 vaccine: next steps towards broad and equitable global access

The University of Oxford in partnership with AstraZeneca has taken the next steps in its commitment to broad and equitable global access to Oxford’s COVID-19 vaccine, following landmark agreements with the Coalition for Epidemic Preparedness Innovations (CEPI), Gavi the Vaccine Alliance, and the Serum Institute of India (SII).

Brazilian Health Regulatory Agency approves trial of Oxford COVID-19 Vaccine

On 2 June, the Brazilian Health Regulatory Agency (ANVISA) approved the inclusion of Brazil in the clinical trials conducted by Oxford University and supported by AstraZeneca, considering 2,000 volunteers to be tested in the country.

First patient recruited in key COVID-19 drug treatment trial

A clinical trial to test whether Azithromycin, a commonly used antibiotic, can treat the symptoms of COVID-19 in outpatients has recruited its first patient.